Harith Rajagopalan

What if the root cause of type 2 diabetes is found in the gut rather than the pancreas?

Share This Talk

Have a suggestion for The Hive?
Submit a Nomination Today

About Harith Rajagopalan

Dr. Harith Rajagopalan is Co-founder and CEO of Fractyl, having started the company while serving as an Entrepreneur-in-Residence at General Catalyst Partners. Prior to founding Fractyl, Harith was an academic cardiologist and physician-scientist. He received his B.S. in Chemistry from Stanford University and went on to obtain M.D. and Ph.D. degrees from Johns Hopkins School of Medicine. At Johns Hopkins, Harith did groundbreaking and award-winning research on intestinal cancers that was published in top medical journals, including Nature and Science. After medical school, Harith trained in internal medicine and clinical cardiology at Brigham and Women’s Hospital and completed a research fellowship at Harvard Medical School before co-founding Fractyl.

Find out more

About This Idea

There are 500 million people around the world suffering from type 2 diabetes. From monitoring blood sugar to taking insulin, diabetic patients are forced to take on a huge responsibility in managing their health.  Fractyl, led by Co-Founder and CEO Harith Rajagopalan, has set out to change the way we treat Type 2 diabetes patients—by shifting the focus from the pancreas to the gut. Watch Harith’s 2017 TEDMED Hive Talk to learn more about how Fractyl’s minimally invasive devices and clinical procedures could help to reduce the massive physical and financial burdens of diabetes management that we face on both individual and societal levels. 

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.